AJP - Gastrointestinal and Liver Physiology, Vol 272, Issue 3 646-G653, Copyright © 1997 by American Physiological Society

ARTICLES

PACAPs stimulate duodenal bicarbonate secretion at PACAP receptors in the rat

K. Takeuchi, K. Takehara, S. Kato and K. Yagi
Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Japan.

We investigated the effects of pituitary adenylate cyclase-activating polypeptides (PACAPs) on gastroduodenal HCO(3)- secretion in anesthetized rats and characterized their effects by comparison with the effects of vasoactive intestinal polypeptide (VIP). Under urethan anesthesia, a rat proximal duodenal loop or a rat stomach mounted in an ex vivo chamber (in the absence of acid secretion) was perfused with saline, and HCO(3)- secretion was measured at pH 7.0 using a pH-stat method and by addition of 10 mM HCl. Intravenous injection of PACAP-27 stimulated HCO(3)- secretion in a dose-dependent manner in the duodenum, but not in the stomach, although this peptide had no effect on duodenal HCO(3)- secretion after intracisternal administration. The duodenal HCO(3)- stimulatory action was similarly observed after intravenous administration of PACAP-38 and VIP, and the potency of action was in the following order: PACAP-27 > PACAP-38 = VIP. The duodenal HCO(3)- stimulatory action of PACAP-27 was potentiated by pretreatment with 3-isobutyl-1-methylxanthine, similar to that of prostaglandin E2, and was significantly attenuated by PACAP-(6--27) (PACAP antagonist) or Ac-Tyr1,D-Phe2-VIP (VIP antagonist) but was not affected by bilateral vagotomy or prior administration of atropine, verapamil, and indomethacin. Forskolin, the stimulator of adenylate cyclase, also increased HCO(3)- secretion in the duodenum, but not in the stomach. These results suggest that 1) PACAP is a potent stimulator of HCO(3)- secretion in the duodenum, but not in the stomach, and may be involved in the peripheral regulation of duodenal HCO(3)- secretion, 2) this action is mediated by adenosine 3',5'-cyclic monophosphate, probably through PACAP and VIP receptors, and 3) adenosine 3',5'-cyclic monophosphate is a mediator in duodenal, but not in gastric, HCO(3)- secretion.

This article has been cited by other articles:

				K. Kita, K. Takahashi, Y. Ohashi, H. Takasuka, E. Aihara, and K. Takeuchi Phosphodiesterase Isozymes Involved in Regulation of Formula Secretion in Isolated Mouse Stomach in Vitro J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 889 - 896. [Abstract] [Full Text] [PDF]

				A. Allen and G. Flemstrom Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin Am J Physiol Cell Physiol, January 1, 2005; 288(1): C1 - C19. [Abstract] [Full Text] [PDF]

				M. Aoi, E. Aihara, M. Nakashima, and K. Takeuchi Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G96 - G103. [Abstract] [Full Text] [PDF]

				D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF]